跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 78,232 条关于
“spinocerebellar ataxia type 1”
全部
78,232
临床试验
51,649
药物
7,672
机构
1,434
资讯
17,477
8个月前
Sarepta Therapeutics Submits Clinical Trial Application for SRP-1005 Huntington's Disease Treatment
6个月前
Vico Therapeutics Advances VO659 with Twice-Annual Dosing in Phase 1/2 Trial for Huntington's Disease and Spinocerebellar Ataxias
去年
Vico Therapeutics' VO659 Shows Promise in Huntington's Disease and Spinocerebellar Ataxias
上个月
Protein Partnership Specificity Explains Regional Brain Vulnerability in SCA1 and Beyond
去年
L-Arginine Shows Promise but Falls Short of Statistical Significance in Spinocerebellar Ataxia Type 6 Trial
去年
Solaxa Advances SLX-100 to Phase 3 Trial for Rare Spinocerebellar Ataxia Type 27B
去年
CIRM Awards $5.69M Grant to Advance Novel Gene Therapy for Spinocerebellar Ataxia Type 3
去年
Biohaven Withdraws EU Application for Spinocerebellar Ataxia Drug Dazluma
去年
FDA Grants Priority Review to Troriluzole for Spinocerebellar Ataxia Treatment
去年
Biohaven Withdraws EU Application for Troriluzole in Spinocerebellar Ataxia, RBC Remains Optimistic
第 1 页，共 1748 页
上一页
下一页
